Developing a Robust In Vitro Intestinal Model for Preclinical Candidate Screening of GI Toxicity

Ron Laethem, Director of Biology at Altis Biosystems, discusses how Altis's intestinal tissue models optimize preclinical screening of GI toxicity.

    • Tags:

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Q: